How much financial support is provided to TB patients under the ni-kshay poshan yojana?

Date:

Under the Ni-kshay Poshan Yojana (NPY)—a Direct Benefit Transfer (DBT) scheme launched by India’s Ministry of Health and Family Welfare under the National Tuberculosis Elimination Programme (NTEP)—TB patients receive financial support to meet their dietary requirements during care.

Financial Support Provided

  • Monthly Cash Assistance: Each notified TB patient receives ₹1,000 per month for the entire duration of their treatment.
  • Total Payment Duration: The financial support is paid continuously throughout the treatment regimen. For standard TB treatment lasting six months, a patient receives a total of ₹6,000. For multi-drug resistant TB (MDR-TB) or extended treatments lasting 9–24 months, payments continue monthly for as long as active treatment is underway.

Key Features of the Financial Assistance

  • Direct Benefit Transfer (DBT): Funds are credited directly into the Aadhaar-linked savings bank account of the beneficiary via the Public Financial Management System (PFMS) to ensure transparency and avoid delays.
  • Universal Eligibility: All TB patients notified on the official NIKSHAY portal—whether receiving treatment in public government hospitals or private healthcare facilities—are eligible.
  • No Alternate Income Criteria: The scheme is non-means-tested, meaning financial aid is available to all patients regardless of income level.
  • Energy-Dense Nutritional Supplementation (EDNS): Severely underweight patients (BMI < 18.5 kg/m²) may receive additional food-based nutritional support during the first two critical months of treatment Alongside the cash benefit.

How to Receive the Assistance

  1. Notification & NIKSHAY Registration: The treating healthcare provider (public or private) registers the patient’s case on the government’s NIKSHAY portal.
  2. Bank Account Details: The patient submits their active bank account details (passbook copy or canceled check) along with their Aadhaar details to the health provider.
  3. Validation & Payout: Once the bank details are verified by PFMS, monthly disbursements commence via SMS-alerted bank transfers.
Payal Rabde
Payal Rabdehttps://www.storifynews.com/
Payal Rabde is a Healthcare Market Research Analyst with experience in the global healthcare and life sciences industry. She contributes to research and consulting projects at Towards Healthcare Research & Consulting and Precedence Research, where she focuses on delivering in-depth market analysis across pharmaceuticals, biotechnology, clinical diagnostics, medical devices, and the broader healthcare sector. She holds an MBA in Pharmaceutical-Biotechnology Management and a Bachelor of Pharmacy (B.Pharm), combining technical knowledge with a strong understanding of healthcare markets. Over the past 4+ years, Payal has worked on a wide range of market research assignments covering market sizing, forecasting, competitive intelligence, opportunity assessment, commercial strategy, epidemiology-based analysis, and technology and industry trend evaluation. Her experience includes conducting primary and secondary research, interviewing key opinion leaders (KOLs), applying data triangulation methods, and using both bottom-up and top-down approaches to market estimation. She has also led research projects for clients across global markets, helping pharmaceutical companies, biotechnology firms, medical device manufacturers, healthcare organizations, and investors gain a clear understanding of market developments and emerging opportunities. At Towards Healthcare Research & Consulting, Payal is committed to producing well-researched, accurate, and practical market insights that support informed business and strategic decisions.

Share post:

Subscribe US

New York
overcast clouds
23.7 ° C
24.6 °
21.1 °
62%
7.6m/s
100%
Fri
25 °
Sat
25 °
Sun
27 °
Mon
25 °
Tue
21 °

Popular

More like this
Related

Maharashtra FDA Crackdown Under Tukaram Mundhe Puts Food Safety and Public Health Under the Spotlight

Tukaram Mundhe, the Maharashtra FDA Commissioner, is currently taking...

India Plans New Health Insurance Rules to Reduce Healthcare Costs

Indian government is now planning to create a new...

India’s Pharma Transformation 2026: From Manufacturing Hub to Innovation Leader

When I look at India’s drug landscape today, I...

Why Asia-Pacific Is Becoming the World’s Next Biotechnology Powerhouse

For a long time, when people talked about biotechnology...